You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Somatostatin

Showing 1 - 25 of 583
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Somatostatin Receptors and GH Receptor Expression on Bone of

Completed
  • Evaluation of the Expression of Somatostatin Receptors and GH Receptor on Bone of Acromegalic Patients
  • Trans-sphenoidal surgery
  • Roma, Italy
    Fondazione Policlinnico Gemelli IRCCS
Apr 6, 2023

Nasopharyngeal Cancer, Epstein-Barr Virus Related Carcinoma Trial in Singapore (FDG-PET, Galium-68 DOTATATE)

Recruiting
  • Nasopharyngeal Cancer
  • Epstein-Barr Virus Related Carcinoma
  • FDG-PET
  • Galium-68 DOTATATE
  • Singapore, Singapore
    National Cancer Centre Singapore
Oct 13, 2022

Satisfaction With Somatostatin Analogue Injections in Acromegaly

Not yet recruiting
  • Acromegaly
    • (no location specified)
    Aug 9, 2022

    Neuroendocrine Tumors Trial in Beijing (Lutetium[177Lu] Oxodotreotide Injection)

    Not yet recruiting
    • Neuroendocrine Tumors
    • Lutetium[177Lu] Oxodotreotide Injection
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    May 30, 2023

    Pancreatic Diseases Trial in Rochester (Somatostatin analog)

    Enrolling by invitation
    • Pancreatic Diseases
    • Somatostatin analog
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Apr 21, 2022

    Neuroendocrine Tumors Trial in Innsbruck, Kraków, Ljubljana ([99mTc]Tc-TECANT1)

    Recruiting
    • Neuroendocrine Tumors
    • Innsbruck, Austria
    • +2 more
    May 12, 2023

    Gastroenteropancreatic Neuroendocrine Tumor Trial in Belgium, Netherlands (Somatostatin analog)

    Not yet recruiting
    • Gastroenteropancreatic Neuroendocrine Tumor
    • Somatostatin analog
    • Brasschaat, Antwerp, Belgium
    • +19 more
    Jan 31, 2023

    Lutathera® in Somatostatin Receptor Positive

    Recruiting
    • Somatostatin Receptor-positive GEP-NET
    • Lutathera
    • Seongnam Si, Gyeonggi Do, Korea, Republic of
    • +4 more
    Jun 29, 2022

    Healthy Trial in Copenhagen, Hvidovre (Proton Pump inhibitor, Placebo)

    Recruiting
    • Healthy
    • Proton Pump inhibitor
    • Placebo
    • Copenhagen, Capital, Denmark
    • +1 more
    Nov 1, 2023

    Carcinoid Tumors Trial in Boston (Ramucirumab, Somatostatin Analog)

    Active, not recruiting
    • Carcinoid Tumors
    • Boston, Massachusetts
    • +1 more
    Apr 14, 2022

    Breast Cancer Stage IV Trial in Irvine (Gallium-68)

    Recruiting
    • Breast Cancer Stage IV
    • Irvine, California
      Hoag Memorial Hospital Presbyterian
    May 26, 2023

    LUTATHERA Injection General Use Result Survey

    Recruiting
    • Somatostatin Receptor-positive Neuroendocrine Tumor
    • LUTATHERA
    • Kashiwa, Chiba, Japan
    • +6 more
    Apr 25, 2023

    Neuroendocrine Tumors Trial in Edmonton (68Ga-HA-DOTATATE)

    Recruiting
    • Neuroendocrine Tumors
    • Edmonton, Alberta, Canada
      University of Alberta
    Apr 11, 2022

    Neuroendocrine Tumors, Carcinoid Tumor, Pulmonary Carcinoid Tumor Trial in Vancouver (177Lu-DOTATOC)

    Not yet recruiting
    • Neuroendocrine Tumors
    • +6 more
    • Vancouver, British Columbia, Canada
      BC Cancer
    Aug 19, 2022

    Neuroblastoma Trial in Lille, Lyon, Toulouse (PRRT with 177Lu-DOTATATE)

    Not yet recruiting
    • Neuroblastoma
    • PRRT with 177Lu-DOTATATE
    • Lille, France
    • +2 more
    Nov 8, 2022

    68-Ga DOTATATE PET/MRI in Diagnosis and Management of

    Recruiting
    • CNS Tumors
    • +6 more
    • Ga68-DOTATATE-PET/MRI
    • New York, New York
      Weill Cornell Medicine
    Sep 20, 2022

    Infective Endocarditis Trial (68Ga-DOTATOC PET/CT)

    Not yet recruiting
    • Infective Endocarditis
    • 68Ga-DOTATOC PET/CT
    • (no location specified)
    Dec 21, 2021

    Neuroendocrine Carcinoma Trial in London (Lu-DOTA-TATE)

    Active, not recruiting
    • Neuroendocrine Carcinoma
    • Lu-DOTA-TATE
    • London, Ontario, Canada
      London Health Sciences Centre
    Apr 5, 2022

    Hepatocellular Carcinoma Trial in France (somatostatin infusion, infusion)

    Recruiting
    • Hepatocellular Carcinoma
    • somatostatin infusion
    • placebo infusion
    • Clichy, France
    • +6 more
    Jan 11, 2022

    Relapsing GH Pituitary Adenomas After Surgery

    Recruiting
    • Acromegaly
      • Strasbourg, France
        Service Médecine Interne, Endocrinologie et Nutrition - Hôpitaux
      Nov 24, 2021

      Hepatocellular Carcinoma Trial in Birmingham ([68Ga]DOTATATE-PET/MRI)

      Completed
      Has Results
      • Hepatocellular Carcinoma
      • Birmingham, Alabama
        University of Alabama at Birmingham Medical Center
      Dec 16, 2022

      Neuroendocrine Neoplasia's (NENs), Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET) Trial in Basel (161Tb-DOTA-LM3,

      Not yet recruiting
      • Neuroendocrine Neoplasia's (NENs)
      • Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)
      • Basel, Switzerland
        Division of Nuclear Medicine, University Hospital Basel
      Apr 27, 2022

      Neuroendocrine Tumors Trial in Portland (Cabozantinib, Lu-177)

      Not yet recruiting
      • Neuroendocrine Tumors
      • Portland, Oregon
        Providence Portland Cancer Institute - Franz Clinic
      Feb 10, 2022

      Neuroendocrine Tumors, Somatostatin Receptor-positive Neuroendocrine Tumor Trial in Madison (Single Photon Emission Computed

      Not yet recruiting
      • Neuroendocrine Tumors
      • Somatostatin Receptor-positive Neuroendocrine Tumor
      • Single Photon Emission Computed Tomography/ Computed Tomography (SPECT/CT)
      • +3 more
      • Madison, Wisconsin
        University of Wisconsin - Madison
      Nov 2, 2023

      Neuroendocrine Tumors Trial in New York (PET/CT Imaging, 68Ga-DOTA-JR11, 177Lu-DOTA-JR11)

      Completed
      Has Results
      • Neuroendocrine Tumors
      • PET/CT Imaging
      • +2 more
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Jan 3, 2022